The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-2-cyclopentyl-2-hydroxy-N-((1S,5R,6s)-3-(naphthalen-2-ylmethyl)-3-aza-bicyclo[3.1.0]hexan-6-yl)-2-phenylacetamide ID: ALA249206
PubChem CID: 10026270
Max Phase: Preclinical
Molecular Formula: C29H32N2O2
Molecular Weight: 440.59
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(N[C@H]1[C@@H]2CN(Cc3ccc4ccccc4c3)C[C@@H]21)C(O)(c1ccccc1)C1CCCC1
Standard InChI: InChI=1S/C29H32N2O2/c32-28(29(33,24-12-6-7-13-24)23-10-2-1-3-11-23)30-27-25-18-31(19-26(25)27)17-20-14-15-21-8-4-5-9-22(21)16-20/h1-5,8-11,14-16,24-27,33H,6-7,12-13,17-19H2,(H,30,32)/t25-,26+,27+,29?
Standard InChI Key: IVSJNZMKHDIKEU-KBHFIQPSSA-N
Molfile:
RDKit 2D
35 40 0 0 1 0 0 0 0 0999 V2000
13.7225 1.9460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1999 2.6220 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.7040 3.2802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9348 2.1920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9280 3.0124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2209 2.5963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3959 2.5894 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.9894 1.8716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1644 1.8647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4078 1.1606 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.3375 1.8708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9312 2.5924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1051 2.5988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6855 1.8852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0981 1.1636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9229 1.1607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1660 2.6897 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.0248 2.6346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9292 1.3708 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
12.9208 3.8375 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
10.1681 1.0395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5009 0.5543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7561 -0.2302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5812 -0.2299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8357 0.5549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4482 1.9266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0429 1.2097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4656 0.5021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2677 1.9446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6927 1.2400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2894 0.5155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7151 -0.1939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5440 -0.1800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9453 0.5492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5173 1.2557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3 5 1 0
9 17 1 0
7 8 1 0
2 18 1 0
5 4 1 0
4 19 1 6
8 9 1 0
5 20 1 6
21 22 1 0
6 5 1 0
8 10 2 0
4 6 1 0
9 11 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 21 1 0
9 21 1 0
11 12 2 0
18 26 1 0
4 1 1 0
26 27 2 0
12 13 1 0
27 28 1 0
28 31 2 0
1 2 1 0
30 29 2 0
29 26 1 0
13 14 2 0
2 3 1 0
30 31 1 0
14 15 1 0
31 32 1 0
6 7 1 6
32 33 2 0
15 16 2 0
33 34 1 0
16 11 1 0
34 35 2 0
35 30 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 440.59Molecular Weight (Monoisotopic): 440.2464AlogP: 4.46#Rotatable Bonds: 6Polar Surface Area: 52.57Molecular Species: BASEHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.98CX Basic pKa: 8.73CX LogP: 4.40CX LogD: 3.06Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.59Np Likeness Score: -0.40
References 1. Kumar N, Kaur K, Aeron S, Dharmarajan S, Silamkoti AD, Mehta A, Gupta S, Chugh A, Gupta JB, Salman M, Palle VP, Cliffe IA.. (2007) Synthesis and optimization of novel and selective muscarinic M(3) receptor antagonists., 17 (18): [PMID:17629699 ] [10.1016/j.bmcl.2007.06.081 ]